Batch Manufacturing Record (BMR): Definition, Components, Format, Lifecycle, and Requirements

A Batch Manufacturing Record (BMR) is a controlled document that captures the entire production history of a product batch, from raw material dispensing to final packaging. The batch manufacturing record, also referred to as a batch production record, or batch record, serves as the core evidence of compliance with Good Manufacturing Practices (GMP), approved Marketing Authorization (MA), and the validated manufacturing process. BMRs are used across GMP-regulated industries, such as pharmaceuticals, biotechnology, cosmetics, and food manufacturing.

Key components of a batch manufacturing record include batch identification details, a reference to the approved Master Batch Record (MBR), raw material details and lot numbers, equipment IDs, manufacturing steps, in-process control data, personnel signatures, deviation references, yield calculations, and batch release decision.

A BMR format is structured in alignment with the master batch record, as defined in internal SOPs. The BMR lifecycle has six key stages, including the controlled printing of the approved MBR, execution of the BMR and real-time data capture, deviation reporting, review of the BMR, approval and batch release, and archival and retention.

The regulatory framework for BMRs is defined by several authorities, including the FDA and European Authorities. The FDA 21 CFR Part 211 mandates that BMRs accurately document every significant manufacturing and control step and must be reviewed by the quality unit before batch release. EU GMP Chapters 1, 4, 5, and 6 outline documentation and traceability requirements, which support batch certification by Qualified Persons. International guidelines such as ICH Q7 and WHO GMP further reinforce traceability, compliance, and quality documentation expectations.

An electronic Quality Management System (eQMS) like SimplerQMS enhances BMR management by centralizing and automating quality processes, such as document control, ensuring only current, approved MBRs are used. SimplerQMS links deviations, CAPAs, change controls, training, equipment calibration, and supplier status, providing better visibility on quality data. Delivered as a validated system according to ISPE GAMP5, SimplerQMS supports BMR management, helping life science companies ensure compliance, product quality, and operational efficiency.

What Is a Batch Manufacturing Record (BMR)?

A Batch Manufacturing Record (BMR) is a controlled document that records the complete production history of a specific batch. A BMR captures actual execution data from raw material dispensing through final packaging. A batch record reflects what was performed, by whom, when it was performed, and which materials and equipment were used.

BMR serves as primary evidence of compliance with Good Manufacturing Practices (GMP) and the approved manufacturing process defined in the product technical dossier. A batch record supports consistent execution of manufacturing steps across batches, reducing batch-to-batch variability that may lead to quality differences.

A batch manufacturing record typically includes batch identifiers such as batch number, batch size, and manufacturing dates, raw material lot numbers and actual quantities used, equipment identifiers, settings, and calibration and cleaning status where required. A batch production record includes step-by-step operator actions, in-process controls, sampling details, and test results, with timestamps and signatures from responsible personnel as verification of each critical step. 

A BMR is essential for batch traceability, quality assurance, and regulatory compliance. A batch manufacturing record documents the complete chain of manufacturing actions, enabling tracing a finished product back to raw material lots, equipment, production lines, and personnel. BMR is the primary evidence that a batch was produced according to validated and approved procedures. A batch manufacturing record demonstrates conformance with the approved technical dossier and marketing authorization.

A batch manufacturing record is required in GMP-regulated industries such as pharmaceuticals, biotechnology, food manufacturing, and cosmetics. A batch record supports ISO 9001 requirements by documenting that processes were executed as planned and that products conform to defined requirements. In the medical device industry, the Device History Record (DHR) is an equivalent requirement, which provides complete traceability for each manufactured device batch and confirms conformity.

A batch manufacturing record supports investigations, audits, and batch release activities. During quality investigations, BMR serves as the primary source of factual data, enabling root cause analysis and effective Corrective Actions and Preventive Actions (CAPAs). BMR supports audits by providing auditors with direct, review-ready evidence of batch compliance. Batch release decisions are based on the review of manufacturing records and test results, confirming that all steps met approved specifications.

What Is the Importance of a Batch Manufacturing Record?

A BMR is important because it proves the consistent and compliant execution of every batch according to GMP and the approved, validated manufacturing process.

The key reasons why the batch record is an essential part of regulated manufacturing processes are given below.

• Ensures Regulatory Compliance: Batch manufacturing record demonstrates that each batch was manufactured in accordance with GMP requirements and the approved marketing authorization.
• Supports Procedural Adherence: The batch record proves that operators followed the approved master instructions step by step during manufacturing.
• Facilitates Real-Time Documentation and Accountability: Batch production record captures data, timestamps, and signatures as work is performed, assigning and documenting the responsibility for each action.
• Enables Complete Traceability: BMR links each batch to specific raw material lots, equipment, utilities, and personnel, enabling end-to-end traceability.
• Provides the Basis for Batch Release: BMR is the documented evidence that all process steps and in-process controls met predefined specifications before release.
• Supports Quality Investigations: The batch manufacturing record provides factual data for deviation handling, root cause analysis, and CAPA determination.
• Ensures Accurate Material and Yield Reconciliation: Batch production record documents material input quantities, losses, and output quantities, allowing accurate yield reconciliation.

What Is the Difference Between Paper and Electronic Batch Manufacturing Records?

The core difference between paper and electronic Batch Manufacturing Records (eBMRs) is how production data is captured, controlled, and archived. Paper batch records are physical, handwritten documents completed manually during production, while electronic batch records are digital records generated, filled, and stored via validated software systems that comply with requirements such as FDA 21 CFR Part 11 and EU GMP Annex 11.

Paper batch records use handwritten timestamps, names, and annotations to document actions and provide an audit trail, which increases the risk of incomplete or incorrect entries. Electronic batch records use secure, time-stamped digital logs with user authentication and access restrictions, which improves data integrity and traceability.

Paper BMRs review and completion involve manual checks that increase the risk of overlooked steps or missing signatures. Electronic BMRs flag missing data, skipped steps, or out-of-limit values in real-time and guide users to correct them on time. Electronic batch records can support automated or semi-automated data capture from equipment and connected systems for higher accuracy.

Paper batch records require physical storage space and remain vulnerable to damage, misfiling, or loss, which may complicate retrieval during audits or quality investigations. Electronic batch records are archived in digital databases that support controlled access and faster search and retrieval.

Paper BMRs demand extensive training to avoid documentation errors and provide no built-in prompts or interlocks. Electronic BMR workflows enforce procedural adherence through mandatory fields and system checks. 

What Is the Difference Between a Batch Manufacturing Record and a Master Batch Record?

The main difference between a Batch Manufacturing Record (BMR) and a Master Batch Record (MBR) is that the MBR defines the approved manufacturing instructions, while the BMR documents the actual execution for a specific batch. The master batch record serves as the controlled template that details materials, equipment, process steps, and parameters, in-process controls, and required documentation for production. The batch manufacturing record represents the completed document that follows this template and records what actually happened during manufacturing for one identified batch.

The batch manufacturing record is batch-specific, capturing real data such as lot numbers, actual quantities used, operator signatures, timestamps, yields, and deviations. The master batch record remains under version control, and only the current approved MBR version is allowed to generate BMRs, preventing the use of outdated instructions.

What Are the Key Components of a Batch Manufacturing Record?

The key components of a batch manufacturing record are listed below.

• Batch Identification Information: The batch record includes product name, strength, dosage form, batch number, batch size, manufacturing and expiry dates, which link all manufacturing data and test results to the specific batch.
• Master Batch Record Reference: Batch manufacturing record references the master batch record version, so reviewers confirm that execution followed the current approved instructions.
• Bill of Materials (BOM): Batch production record lists each raw material used with material codes, descriptions, required, dispensed, and used quantities, and received lot numbers to secure full material traceability.
• Equipment and Facilities: Batch record documents equipment identifiers, line or room numbers, cleaning status, and, if required, calibration or qualification status, linking the batch to specific equipment and production rooms.
• Manufacturing Steps: The master batch record details each manufacturing step in sequence. In the batch record, the actual start and end times, process parameters, and operator or supervisor signatures are documented to give evidence of how the batch was produced.
• In-Process Controls (IPCs): Batch record captures sampling points, specifications, actual results, and disposition decisions for intermediates and bulk, along with the relevant signatures of QC personnel, which demonstrates that the process stayed in control and met predefined limits.
• Personnel Accountability: Batch manufacturing record includes names and signatures of operators, supervisors, and quality personnel for each critical step, promoting accountability and supporting data integrity.
• Yield Calculation and Reconciliation: Batch manufacturing record documents theoretical yields and actual yields at key stages, losses, and reconciliation of material quantities. This step confirms if the yield and reconciliation are within predefined limits, supporting control over the manufacturing process.
• Labels: Batch production record includes all the labels, such as intermediate product release labels and cleaning labels, used during the production of the specific batch, as proof. Through labels, the clean status of the room and equipment, or that an intermediate has been released before proceeding to the next manufacturing step, can be confirmed during batch record review.
• Deviation Reference: In BMR, any deviation that occurred during the manufacturing process is referenced with the corresponding number, which enables rapid access to investigation and impact assessment during review and batch release decision.
• Final Review Checklist: BMR typically includes a structured checklist for production and quality reviewers to verify completeness, strengthen data integrity, and audit readiness.
• Batch Release Decision: Batch production record documents the formal batch disposition decision by QA, including release, reject, or quarantine status, decision date, and QA or Qualified Person (QP) signature.

What Does a Standard BMR Format Look Like?

A BMR follows a standard structure that organizes all batch data into clear sections to support process adherence, GMP compliance, traceability, and quality assurance. The batch records format follows the approved master batch record layout. The batch record structure is typically defined in an internal Standard Operating Procedure (SOP).

A batch record typically uses table structures whenever repeated or structured data must be documented in real time. Table structures with specific columns are used for material dispensing, equipment use, process parameters at multiple timepoints, in-process controls results, and yield reconciliation.

Batch manufacturing records keep a similar core structure across dosage forms but adapt sections and tables to dosage-specific operations and controls. For instance, a batch record for tablets includes defined sections for granulation, compression, coating, and IPC tables for tablet weight, hardness, thickness, and friability. A batch record for injections includes sections for solution preparation, filtration, sterilization, and container closure integrity checks. A batch record for syrups includes sections for solution preparation, pH or density checks, and volume controls. A batch manufacturing record for ointments and creams includes sections for phase preparation, emulsification, homogenization, and filling weight control.

The batch record format is defined by the master batch record. Resources that guide batch record format include the following.

• Regulatory Guidelines: The batch record format is based on GMP requirements, which define required content and documentation principles for batch records, but not a fixed layout.
• Industry Templates: Batch record format is defined by industry templates that translate regulatory expectations into concrete sections, tables, and signature fields.
• Electronic Batch Record: Batch record format in eBMR systems is implemented as digitalized workflows and report layouts that mirror the master batch record and internal SOPs.

What Are the Different Lifecycle Phases of Batch Manufacturing Records?

There are six main lifecycle phases of a batch manufacturing record, and they describe how batch documentation moves through controlled stages from template printing to final archival. BMR lifecycle ensures that every batch record remains controlled, complete, and trustworthy for its entire retention period.

The six lifecycle phases are listed below.

1. Controlled Printing of Master Batch Record: The Production or QA department prints a controlled copy of the current approved MBR to prevent the use of outdated or unofficial instructions and duplicate prints.
2. Execution of the BMR and Data Capture: Production operators and IPC analysts record real-time data and results as they execute each step and then sign them, creating a factual history of batch manufacture.
3. Deviation Reporting: Any deviation from instructions or any test result that is out of specification limits is documented in the BMR, reported to QA, and linked to formal deviation records.
4. Review of the BMR: Production and quality responsible personnel perform batch record review for completeness, legibility, accuracy of calculations, and proper linkage to investigations or deviations before disposition.
5. BMR Approval and Batch Release: QA, QC, and production management confirm compliance with specifications, approved processes, and GMP, and document the formal release or rejection decision.
6. Archiving and Retention of the BMR: The approved record is stored securely for the defined retention period, indexed for rapid retrieval during audits or investigations.

Batch manufacturing record lifecycle management is required under GMP and data integrity frameworks because it is a critical document proving the quality and safety of each batch. Data included in the batch record must be attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available for the full record lifecycle, supporting batch release decision.

1. Controlled Printing of Master Batch Record

The controlled printing of the master batch record phase refers to the controlled process where the current and approved MBR template is printed to create a working copy for a specific batch manufacturing record. Controlled printing of the MBR phase’s objective is to ensure that only the correct version of the manufacturing instruction reaches the shop floor, and that no duplicate or unauthorized copies exist that could compromise product integrity or enable falsification.

Controlled printing of the MBR phase typically involves production and QA personnel. Production initiates a controlled print request and receives the printed copy, while QA reviews and approves the request and performs reconciliation of issued and returned controlled copies. In an electronic system with built-in print control, the system may perform these controls without QA personnel intervention.

Controlled printing of the MBR requires, at the start, an approved MBR, a production schedule, and a controlled print request that identifies product and batch size. Controlled printing of the MBR includes tasks such as request initiation by production, authorization and verification by QA, execution of printing, and application of a footer or watermark such as “Controlled Copy” with print date, time, and responsible person. In the case of computerized systems, this information may be printed automatically.

Controlled printing of the MBR aligns with GMP and data integrity expectations. FDA 21 CFR Part 211 in paragraph 211.188 (a) states that working documents must be accurate reproductions of master documents, checked for accuracy, dated, and signed. Complementing Part 211, EU GMP in Chapter 4 requires that the reproduction of working documents from master documents should not introduce any error through the reproduction process. Controlled printing of an approved MBR should generate a single, version-controlled issued copy, ready for real-time completion as the BMR for that specific batch.

2. Execution of the BMR and Data Capture

Execution of the batch manufacturing record and data capture phase covers real-time recording of all manufacturing and control activities for a specific batch. The BMR execution phase has the objective to create a complete, contemporaneous, and accurate history of how the batch was produced and tested, supporting traceability, process control, and compliance with GMP and marketing authorization.

The execution of the BMR is mainly the responsibility of production operators and supervisors who perform and document the work. Production personnel are supported by QC personnel who perform and record in-process sampling and testing, and by QA, who may provide on-the-floor oversight in some organizations.

Execution of the BMR phase requires, at the start, the controlled printed or electronic BMR generated from the approved MBR, released and properly labelled raw materials, equipment, and line clearance records, and relevant support documents such as logbooks or calibration records. Execution of the BMR and data capture phase includes tasks such as performing each instruction exactly as written, entering actual values (times, quantities, parameters, results) at the time of performance, recording material lot numbers and equipment IDs, documenting in-process controls, attaching supporting printouts or labels, and completing required signatures or electronic signatures for each critical step.

The BMR execution phase works in parallel with QC work, where QC performs sampling, conducts analyses, records results for intermediate or bulk product testing, and compiles the batch control record that contains all analytical data and results linked to the BMR.

The batch manufacturing record execution and data capture phase must meet GMP and data integrity requirements such as ALCOA+, ensuring entries are attributable, legible, contemporaneous, original, and accurate. BMR entries must be made in real time, in indelible ink or validated electronic systems, without leaving blank spaces or using correction fluid, and corrections must be made with a single line, dated, and signed with a reason where needed. BMR execution in electronic systems must rely on controlled user access and audit trails.

Batch record execution phase outputs a fully completed BMR with all required data fields filled, all in-process control records attached or referenced, all operator and supervisor signatures captured, and all QC results compiled in the associated batch control record, ready for formal review and disposition.

3. Deviation Reporting

The deviation reporting phase concerns the identification, documentation, and assessment of any deviation from approved instructions, limits, or GMP requirements during batch manufacture and testing. The deviation reporting phase runs concurrently with BMR execution, because personnel should report the deviation when it happens, not after completion of all steps.

The deviation reporting phase has the objective to ensure that every deviation is captured in real time, assessed for impact on product quality, safety, and efficacy, and linked to the affected batch record.

The deviation reporting involves production operators and supervisors who detect and initiate deviation reports, QC who report analytical deviations and provide supporting data, and QA and QP, where applicable, who assess, classify, and approve conclusions and follow-up actions.

Deviation reporting requires the BMR in use, relevant SOPs for deviation management, applicable specifications and limits, and any immediately available data such as readings, samples, or test results. Deviation reporting includes tasks such as immediate notification of the supervisor, initiation of a deviation record with date, time, and description, attachment or reference to supporting evidence, classification of criticality, and assignment of investigation to responsible QA or Operations personnel.

Deviation reporting and management must follow GMP and data integrity requirements that require timely, attributable, and complete documentation and investigation of any deviation from approved written procedures.

For EU GMP-certified companies, the deviation reporting phase must support compliance with EU GMP Annex 16, and the QP certifying a batch must remain aware of all deviations with potential GMP or MA impact and base the certification decision on a documented assessment concluding that any impact is negligible before batch release.

The deviation reporting phase outputs include a formal deviation record linked to the specific BMR, containing the documented investigation, impact assessment, conclusions, required CAPAs where applicable, and signatures or approvals from QA and, when required, the Qualified Person.

4. Review of the BMR

Review of the batch manufacturing record is the systematic evaluation of completed entries to verify that the batch has been documented accurately and completely. The purpose of the BMR review phase is to detect and correct documentation issues, confirm that all process steps and controls were performed as required, and ensure the record is ready for batch release decisions.

The BMR review process involves production supervisors, QC supervisors, and, later, QA reviewers. Production and QC supervisors usually review sub-sections immediately after a manufacturing step. For example, upon completion of a production step, yield and reconciliation calculations are verified by the production supervisor, and in-process control testing and results are verified by the QC supervisor. A reviewer may be present on the spot for critical steps such as raw material dispensing.

The BMR review requires the completed BMR and raw data, applicable SOPs, relevant analytical reports or batch control records, and any linked deviation or change-control documentation. Batch record review includes actions such as checking that all fields are filled, verifying dates and times, confirming correct material codes and lot numbers, re-checking yield and reconciliation calculations, comparing recorded process parameters and in-process control results with specifications, and ensuring all required signatures are present and legible.

The batch record review phase must comply with GMP and data integrity expectations. Reviewers must not obscure original data, must document any corrections properly, and must date and sign reviews. The outputs of the BMR review phase include documented reviewer comments where needed, completed BMR entries, and reviewer signatures.

Batch record review often reveals common errors such as missing or undated signatures, incomplete fields, incorrect material lot numbers, illegible handwriting, overwriting of data instead of documented corrections, unrecorded or inadequately referenced deviations, inconsistent times or sequence of steps, discrepancies between BMR entries and QC laboratory records, and incorrect yield or reconciliation calculations.

The BMR review benefits strongly from a structured review checklist, particularly for paper BMRs, because the checklist guides reviewers through each critical element and reduces the risk of overlooking documentation or data integrity issues.

5. BMR Approval and Batch Release

The batch record approval and batch release refer to the final quality decision on whether a batch is released or rejected. The purpose of the BMR approval and batch release phase is to confirm that manufacturing and testing complied with the approved instructions, specifications, and GMP requirements before the product is released to saleable stock.

The BMR approval and batch release phase involves production and QC management, QA, and, where applicable, the QP for certification of medicinal products.

BMR approval and batch release require the fully completed BMR, the QC batch control record with all test results, certificates of analysis, deviation and change control reports where applicable, environmental monitoring records, cleaning records, and any other documents defined in internal procedures for batch release. The batch record approval and batch release phase includes tasks such as verifying that all required processing, packaging, and labeling steps were reviewed, checking that all analytical results meet specifications, and confirming that all deviations have documented impact assessments and were properly resolved.

Batch record approval and batch release must follow GMP and data integrity requirements. EU GMP Chapter 4 states that the batch record must be approved by the person responsible for the processing operations. EU GMP Annex 16 includes the requirements for batch release and details the QP responsibilities. FDA 21 CFR Part 211 states that production and control records must be reviewed and approved by the quality control unit before any batch is released.

The BMR approval and batch release phase produces the formal QA approval signatures and, where required, the QP certification signatures in the BMR, along with a documented batch disposition decision. The batch release decision shall also be documented in corresponding entries in inventory or ERP systems that authorize or block the distribution of that specific batch.

6. Archiving and Retention of the BMR

The archiving and retention of the batch manufacturing record phase covers secure storage of the completed and approved batch documentation for the required retention period. Archiving and retention of the BMR phase has the objective to ensure that batch records remain available for inspections, investigations, and any market actions throughout the product life.

Archiving and retention of the BMR usually involves the QA as process owner, supported by IT for electronic systems. Archival and retention of the BMR phase includes tasks such as assigning archive identifiers, indexing records by product and batch, storing paper records in protected, access-controlled areas, or loading electronic records into secure, validated systems, and defining and controlling who may view, copy, or retrieve them.

Archiving and retention of the BMR phase must meet GMP and data integrity expectations that records stay complete, readable, and protected against loss, damage, or unauthorized change. Access must be controlled, and any retrieval or re-printing must not alter the original record.

Archiving and retention of the BMR must follow retention timelines defined in applicable requirements. EU GMP Chapter 4 requires batch documentation to be kept for one year after expiry of the batch or at least five years after certification by the Qualified Person, whichever period is longer. FDA 21 CFR Part 211 requires production, control, and distribution records associated with a batch of drug product to be retained for at least one year after the batch expiration date.

Archiving and retention of the BMR results in securely stored and easily retrievable batch records, ensuring that any BMR for a released batch remains accessible and trustworthy.

What Are the Regulatory Requirements For Batch Manufacturing Records?

Batch manufacturing record requirements are defined in several GMP and quality frameworks, including EU GMP, FDA Part 211, and ISO 9001. EU GMP requirements apply to batches manufactured or imported into the European market, while FDA 21 CFR Part 211 requirements apply to batches manufactured or imported into the U.S. market. PIC/S and WHO GMP guidelines for drug products and ICH Q7 for active pharmaceutical ingredients influence national GMP requirements and support the harmonization of expectations globally, although they are not legally binding.

The different requirements for BMR are listed below.

• FDA 21 CFR Part 211: Part 211 states that the BMR must be an accurate reproduction of the master production record and must include complete documentation of all significant manufacturing steps, such as dates, identification of persons performing or supervising the steps, major equipment used, identification of each batch, and weight of components used. The BMR must also document sampling, IPC, and laboratory results, labeling control, inspection of the packaging and labeling area before and after use, and details of any deviations. The BMR must be fully reviewed and approved by the quality control unit before batch release.
• EU GMP Chapters 1, 4, 5, 6, and Annex 16: EU GMP requires batch manufacturing records to document all relevant manufacturing and testing activities, support traceability, and be prepared, checked, and approved by responsible persons. Documentation requirements in Chapter 4, production requirements in Chapter 5, and quality control requirements in Chapter 6 together mandate complete, legible, contemporaneous batch documentation that enables the Qualified Person to certify the batch. Annex 16 includes the requirements for the certification and batch release by a Qualified Person.
• ICH Q7: ICH Q7 for active pharmaceutical ingredients states that the batch record must include complete information on the production and control of each batch, including raw materials and any reprocessed materials used, critical processing conditions, in-process controls and results, yields, and any deviation noted. Batch records must ensure traceability and support review.
• WHO GMP (TRS 986 – Annex 2): According to WHO GMP guidelines, the batch record forms part of the essential GMP documentation and must provide detailed instructions and a full record for the manufacture and control of each batch of bulk or finished product. WHO GMP requires that completed batch records are reviewed and evaluated by the head(s) of the quality unit.
• ISO 9001:2015: In the ISO 9001:2015 standard for quality management systems, the batch manufacturing record is not named explicitly but is covered by requirements for documented information that demonstrates that processes are carried out as planned and that products conform to specified requirements.

How Can QMS Software Streamline the BMR Management Process?

A Quality Management System (QMS) software streamlines the batch manufacturing record management process by controlling master documents, automating quality workflows, and interlinking related quality data such as deviations, CAPAs, equipment, and supplier records.

Key QMS capabilities that support BMR management include the following.

• Document Control and Version Management: QMS software stores master batch records and SOPs under version control, applies electronic signatures, and ensures only the current approved version is used for printing or execution, reducing the risk of outdated instructions and minimizing manual QA involvement in document control.
• Deviation and CAPA Management: QMS software streamlines deviation management and links deviations to related CAPA workflows, supporting a closed-loop process from event detection through investigation, action implementation, and effectiveness check. QMS software can integrate with an electronic batch record and link deviations raised during batch execution to the specific BMR.
• OOS Management: QMS software helps register out-of-specification (OOS) results as quality events in a central repository, attach analytical data, manage investigations, and record conclusions, keeping QC batch control records, BMRs, and quality investigations aligned and traceable.
• Equipment Management: QMS software maintains equipment management data, such as calibration and maintenance records, and qualification status, and allows users to verify equipment status prior to use or scheduling for use in production.
• Change Management: Within aQMS software, changes to master batch records, specifications, and related procedures are centrally managed, providing easy visibility on implementation tracking.
• Supplier Management: In QMS software, supplier qualification, including approved vendor lists, is centrally managed, making it easier to verify if the raw materials planned to be used in production originate from qualified sources with up-to-date approvals and documentation.

QMS software brings clear benefits for BMR management. The batch record printing can be controlled using document control features. The review effort is reduced through better linkage between BMRs and quality procedures. Visibility improves by providing access to materials, equipment, training, and supplier status in a unified platform. QMS software provides compliance advantages by improving audit readiness because records and supporting evidence stay organized, searchable, and readily retrievable.

A life science–focused eQMS, such as SimplerQMS, can support batch record management. SimplerQMS is delivered as a fully validated QMS software following GAMP5 principles and supports compliance with FDA 21 CFR Parts 210, 211, 820, EU-GMP, ICH Q10 requirements, and more. SimplerQMS complies with FDA Part 11 and EU-GMP Annex 11.

SimplerQMS helps life science companies manage their batch manufacturing records by centralizing and streamlining key quality processes. SimplerQMS document control and change control modules manage master documents, including MBRs and related SOPs, under version control, with compliant electronic signatures and audit trails. Deviation, complaint, CAPA, and change management modules link quality data and investigations directly to affected batches and products, supporting root cause analysis and continuous improvement. Equipment, supplier, and training management modules maintain the supporting evidence that regulators expect around each batch, such as qualified equipment, approved suppliers, and trained personnel.